CME Earnings Estimate

CME Stock  USD 232.71  0.40  0.17%   
The next projected EPS of CME is estimated to be 2.5472 with future projections ranging from a low of 2.535 to a high of 2.57. CME's most recent 12-month trailing earnings per share (EPS TTM) is at 9.52. Please be aware that the consensus of earnings estimates for CME Group is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
CME is projected to generate 2.5472 in earnings per share on the 31st of December 2024. CME earnings estimates show analyst consensus about projected CME Group EPS (Earning Per Share). It derives the highest and the lowest estimates based on CME's historical volatility. Many public companies, such as CME, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

CME Revenue Breakdown by Earning Segment

By analyzing CME's earnings estimates, investors can diagnose different trends across CME's analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit is expected to grow to about 5.7 B, whereas Pretax Profit Margin is forecasted to decline to 0.43.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

CME Earnings Estimation Breakdown

The calculation of CME's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CME is estimated to be 2.5472 with the future projection ranging from a low of 2.535 to a high of 2.57. Please be aware that this consensus of annual earnings estimates for CME Group is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
2.68
2.54
Lowest
Expected EPS
2.5472
2.57
Highest

CME Earnings Projection Consensus

Suppose the current estimates of CME's value are higher than the current market price of the CME stock. In this case, investors may conclude that CME is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CME's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
1897.88%
2.68
2.5472
9.52

CME Earnings per Share Projection vs Actual

Actual Earning per Share of CME refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering CME Group predict the company's earnings will be in the future. The higher the earnings per share of CME, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

CME Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as CME, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of CME should always be considered in relation to other companies to make a more educated investment decision.

CME Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact CME's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-10-23
2024-09-302.662.680.02
2024-07-24
2024-06-302.532.560.03
2024-04-24
2024-03-312.452.50.05
2024-02-14
2023-12-312.282.370.09
2023-10-25
2023-09-302.222.250.03
2023-07-26
2023-06-302.22.30.1
2023-04-26
2023-03-312.382.420.04
2023-02-08
2022-12-311.881.920.04
2022-10-26
2022-09-301.941.980.04
2022-07-27
2022-06-301.931.970.04
2022-04-27
2022-03-3122.110.11
2022-02-09
2021-12-311.641.660.02
2021-10-27
2021-09-301.561.60.04
2021-07-28
2021-06-301.611.640.03
2021-04-28
2021-03-311.751.790.04
2021-02-10
2020-12-311.371.390.02
2020-10-28
2020-09-301.411.38-0.03
2020-07-29
2020-06-301.621.630.01
2020-04-29
2020-03-312.232.330.1
2020-02-12
2019-12-311.541.52-0.02
2019-10-30
2019-09-301.761.90.14
2019-07-31
2019-06-301.761.760.0
2019-05-01
2019-03-311.61.620.02
2019-02-14
2018-12-311.721.770.05
2018-10-25
2018-09-301.431.450.02
2018-07-26
2018-06-301.721.740.02
2018-04-26
2018-03-311.831.860.03
2018-02-01
2017-12-311.091.120.03
2017-10-26
2017-09-301.161.190.03
2017-08-01
2017-06-301.211.230.02
2017-04-27
2017-03-311.21.220.02
2017-02-02
2016-12-311.111.140.03
2016-10-27
2016-09-301.041.050.01
2016-07-28
2016-06-301.111.140.03
2016-04-28
2016-03-311.151.150.0
2016-02-05
2015-12-310.90.920.02
2015-10-29
2015-09-300.991.020.03
2015-07-30
2015-06-300.920.950.03
2015-04-30
2015-03-310.950.980.03
2015-02-05
2014-12-310.930.950.02
2014-10-30
2014-09-300.830.840.01
2014-07-31
2014-06-300.790.77-0.02
2014-05-01
2014-03-310.830.830.0
2014-02-04
2013-12-310.680.64-0.04
2013-11-04
2013-09-300.730.750.02
2013-08-01
2013-06-300.890.930.04
2013-05-02
2013-03-310.730.730.0
2013-02-05
2012-12-310.630.630.0
2012-10-25
2012-09-300.690.70.01
2012-07-26
2012-06-300.820.890.07
2012-04-26
2012-03-310.80.80.0
2012-02-02
2011-12-310.730.71-0.02
2011-11-01
2011-09-300.940.950.01
2011-07-28
2011-06-300.830.880.05
2011-04-28
2011-03-310.840.870.03
2011-02-03
2010-12-310.760.75-0.01
2010-10-28
2010-09-300.730.730.0
2010-07-29
2010-06-300.880.890.01
2010-04-29
2010-03-310.720.720.0
2010-02-04
2009-12-310.690.67-0.02
2009-10-29
2009-09-300.660.670.01
2009-07-23
2009-06-300.650.670.02
2009-04-23
2009-03-310.640.640.0
2009-02-03
2008-12-310.690.720.03
2008-10-29
2008-09-300.80.830.03
2008-07-22
2008-06-300.770.790.02
2008-04-22
2008-03-310.960.93-0.03
2008-02-05
2007-12-310.720.750.03
2007-10-24
2007-09-300.820.860.04
2007-07-24
2007-06-300.730.740.01
2007-04-24
2007-03-310.720.740.02
2007-01-30
2006-12-310.60.58-0.02
2006-10-24
2006-09-300.570.590.02
2006-07-25
2006-06-300.620.620.0
2006-04-25
2006-03-310.530.52-0.01
2006-01-31
2005-12-310.420.440.02
2005-10-25
2005-09-300.440.440.0
2005-07-26
2005-06-300.480.47-0.01
2005-04-26
2005-03-310.390.410.02
2005-02-01
2004-12-310.340.33-0.01
2004-10-26
2004-09-300.330.340.01
2004-07-22
2004-06-300.330.330.0
2004-04-27
2004-03-310.240.270.0312 
2004-02-03
2003-12-310.180.17-0.01
2003-10-22
2003-09-300.180.190.01
2003-07-22
2003-06-300.190.210.0210 
2003-04-22
2003-03-310.130.150.0215 
2003-01-30
2002-12-310.180.180.0

About CME Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CME earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CME estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CME fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings5.1 BB
Retained Earnings Total Equity5.9 B3.7 B
Earnings Yield 0.04  0.03 
Price Earnings Ratio 21.09  13.02 
Price Earnings To Growth Ratio 1.37  0.86 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Financial Exchanges & Data space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.214
Dividend Share
4.55
Earnings Share
9.52
Revenue Per Share
16.795
Quarterly Revenue Growth
0.185
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.